Serum amyloid P component binding to Shiga toxin 2 requires both A subunit and B pentamer

被引:22
作者
Marcato, P [1 ]
Vander Helm, K [1 ]
Mulvey, GL [1 ]
Armstrong, GD [1 ]
机构
[1] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2H7, Canada
关键词
D O I
10.1128/IAI.71.10.6075-6078.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Solid-phase binding, competitive binding, and cytotoxicity neutralization assays indicate that the B pentamer and A subunit both contribute to human serum amyloid P (HuSAP) component binding to Stx2. A polyvalent globotriaosyl-ceramide receptor analog, Daisy, did not competitively inhibit HuSAP binding, implying that the two ligands bind to different Stx2 domains.
引用
收藏
页码:6075 / 6078
页数:4
相关论文
共 17 条
[1]   INVESTIGATION OF SHIGA-LIKE TOXIN BINDING TO CHEMICALLY SYNTHESIZED OLIGOSACCHARIDE SEQUENCES [J].
ARMSTRONG, GD ;
FODOR, E ;
VANMAELE, R .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (06) :1160-1167
[2]   Epidemic of gastrointestinal tract infection including hemorrhagic colitis attributable to Shiga toxin 1-producing Escherichia coli O118:H2 at a junior high school in Japan [J].
Hashimoto, H ;
Mizukoshi, K ;
Nishi, M ;
Kawakita, T ;
Hasui, S ;
Kato, Y ;
Ueno, Y ;
Takeya, R ;
Okuda, N ;
Takeda, T .
PEDIATRICS, 1999, 103 (01) :E2
[3]  
HEAD SC, 1991, J BIOL CHEM, V266, P3617
[4]   Role of Shiga toxin 2 (Stx2)-binding protein, human serum amyloid P component (HuSAP), in Shiga toxin-producing Escherichia coli infections:: assumption from in vitro and in vivo study using HuSAP and anti-Stx2 humanized monoclonal antibody TMA-15 [J].
Kimura, T ;
Tani, S ;
Motoki, M ;
Matsumoto, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 305 (04) :1057-1060
[5]   Serum amyloid P component is the shiga toxin 2-neutralizing factor in human blood [J].
Kimura, T ;
Tani, S ;
Matsumoto, Y ;
Takeda, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) :41576-41579
[6]   HEMOLYTIC UREMIC SYNDROMES IN THE BRITISH-ISLES, 1985-8 - ASSOCIATION WITH VEROCYTOTOXIN PRODUCING ESCHERICHIA-COLI .2. MICROBIOLOGICAL ASPECTS [J].
KLEANTHOUS, H ;
SMITH, HR ;
SCOTLAND, SM ;
GROSS, RJ ;
ROWE, B ;
TAYLOR, CM ;
MILFORD, DV .
ARCHIVES OF DISEASE IN CHILDHOOD, 1990, 65 (07) :722-727
[7]   SPECIFIC INTERACTION OF ESCHERICHIA-COLI O157/H7-DERIVED SHIGA-LIKE TOXIN-II WITH HUMAN RENAL ENDOTHELIAL-CELLS [J].
LOUISE, CB ;
OBRIG, TG .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (05) :1397-1401
[8]   RETRACTED: Cloned Shiga toxin 2 B subunit induces apoptosis in ramos Burkitt's lymphoma B cells (Retracted Article. See vol 71, pg 4828, 2003) [J].
Marcato, P ;
Mulvey, G ;
Armstrong, GD .
INFECTION AND IMMUNITY, 2002, 70 (03) :1279-1286
[9]   Immunoprophylactic potential of cloned shiga toxin 2 B subunit [J].
Marcato, P ;
Mulvey, G ;
Read, RJ ;
Vander Helm, K ;
Nation, PN ;
Armstrong, GD .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (03) :435-443
[10]   Affinity purification of Shiga-like toxin I and Shiga-like toxin II [J].
Mulvey, G ;
Vanmaele, R ;
Mrazek, M ;
Cahill, M ;
Armstrong, GD .
JOURNAL OF MICROBIOLOGICAL METHODS, 1998, 32 (03) :247-252